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ABSTRACT
Protection of ascorbic acid (AA: vitamin C) from Cu(II)-catalyzed autoxidation is an important aspect of antioxidant chemistry.
The autoxidation of AA in the absence and presence of Cu(II) ions was investigated in aerated solution at room temperature and
I = 0.1 ionic strength (KNO3).   Effects of eight biochemically important amino acids (alanine, glycine, aspartic acid, asparagine,
glutamic acid, glutamine, phenylalanine, and histidine) on this system were studied.  The concentration of unoxidized AA remaining
in solution was measured with the CUPRAC (cupric ion reducing antioxidant capacity) spectrophotometric method without interference from the amino acids tested.  The autoxidation rate constants of AA decreased with increasing amino acid concentration for
fixed Cu, and increased with Cu(II) for fixed amino acid concentrations. Catalytic autoxidation of AA was inhibited by stable Cuamino acid complexes; histidine, having the highest conditional stability constant for its Cu-complex, showed the strongest inhibitive effect.  Since amino acids are food and drug compatible compounds, they can be used in commercial products to increase the
stability of vitamin C.
Key words: ascorbic acid, vitamin C, autoxidation, copper(II) catalysis, amino acids, protection, antioxidants

INTRODUCTION
Ascorbic acid (AA: vitamin C) is a water-soluble
antioxidant vitamin that participates in many biochemical
reactions. AA exists in nature in the reduced (L-ascorbic
acid) and oxidized (dehydroascorbic acid) forms.  AA is
rather unstable with respect to light, air oxygen, other
oxidants, alkalis and transition metals.   One of its main
biochemical roles is the decrease of oxidation hazards on
the cell metabolism (1).   It may be added as supplement
to various food and vitamin products, and its stability
in such environments depends on food composition, pH,
and oxygen content (2).
Traces of transition metal ions like Cu(II) and Fe(III)
may act as catalysts in the autoxidation of ascorbic acid.
Because of its biochemical importance in the food and
pharmaceutical industries, Cu(II)-catalyzed oxidation of
AA by molecular oxygen has been extensively studied (35)
. It has been found that the catalytic efficiency of Cu(II)
complexes on AA autoxidation depends on the nature of
the ligands and on the coordination geometry of the metal
ion(6).   Complexation of Cu(II) and Fe(III) by certain
ligands such as EDTA, CDTA, NTA, citrate, acetate,
* Author for correspondence.  Tel: +90-212-4737028;
Fax: +90-212-5268433; E-mail: rapak@istanbul.edu.tr

tartrate, phthalate, bishistidine and glutathione modifies
catalytic activity(3,4,7-10).  Stability of the cupric or ferric
chelate was shown by Khan and Martell to be linearly
correlated to its catalytic activity in AA oxidation(3,4).
Amino acids are the building blocks of proteins.
Proteins are synthesized in the organism from amino
acids, and converted into 20 structurally different amino
acids upon hydrolysis.   Amino acids may undergo various changes in metabolism, and may convert into raw
materials for the synthesis of other essentially important
substances, e.g. haemoglobin, the oxygen transport ironprotein of red blood cells(11,12).  Since amino acids show
a strong potential for binding transition metal ions like
Cu(II) and Fe(III), they may act as synergic agents or
protective antioxidants in systems bearing AA.  Although
Cu(II)-amino acid prototype compounds have been studied for understanding the mechanism of copper-biopolymer binding(13), there are relatively few reports in literature for synergic combinations of antioxidants, especially
metal sequestering type antioxidants that prevent oxidative degradation reactions.  Since AA may act as a reducing agent toward Fe(III) and Cu(II), the lower oxidation
states of these metal ions thus formed may give Fenton
reactions with hydrogen peroxide (14), producing the
highly reactive hydroxyl radical (.OH) resulting in tissue
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damage.   Therefore, AA may act as a mediator of lipid
peroxidation through redox cycling of transition metal
ions (15).   Thus, it is biochemically important to see the
potential AA-stabilizing effect of amino acids.
This study aims to investigate the copper-binding
(therefore AA-protective) roles of eight biochemically
important amino acids (i.e. alanine, glycine, aspartic acid,
asparagine, glutamic acid, glutamine, phenylalanine, and
histidine) in aerated solution at pH 4.5, room temperature,
and constant ionic strength. Phenylalanine and histidine
are essential, whereas glycine and glutamine are conditionally essential (i.e. to be supplied exogeneously to
specific populations) amino acids. Alanine and glycine
are osmolytes of quantitative importance in cell volume
regulation.   Both amino acids, and additionally aspartic
acid, asparagine, and glutamic acid take part in neurotransmission in the mammalian nervous system(16-18).
The concentration of AA remaining in solution as a function of time was measured with the cupric-neocuproine
spectrophotometric reagent (19).  This reagent is the chromogenic oxidant of the CUPRAC assay of total antioxidant capacity (TAC)(20,21), arising not only from AA but
from certain other vitamins (e.g. vitamin E), antioxidant
phenolics (e.g. phenolic and hydroxycinnamic acids), and
flavonoids. This method practically met no interference
from the tested amino acids and other UV-Vis absorbing
compounds in AA determinations.

MATERIALS AND METHODS
I. Chemicals and Instruments
All chemicals were of analytical reagent grade and
were supplied by E. Merck (AG, Darmstadt, Germany).
L-ascorbic acid (mentioned as ascorbic acid in the text)
was used without purification. Cu(II)-Nc (neocuproine) reagent was prepared from CuCl 2 and neocuproine
(2,9-dimethyl-1,10-phenanthroline) and used for AA
assay as described elsewhere (19).   In investigating Cucatalyzed autoxidation of AA, amino acids (i.e., alanine,
glycine, aspartic acid, asparagine, glutamic acid, glutamine, phenylalanine, and histidine) were used as possible
copper chelators.   These Cu-amino acid chelates were
prepared in 0.01 M acetate buffer at pH 4.5, prepared
according to Hsieh and Harris(22).   Deionized distilled
water was used throughout.
The CUPRAC spectrophotometric determination of
AA was carried out using a mixture of Cu(II) and neocuproine as chromogenic oxidant (19).  The pH of the medium
was 7.0 (adjusted with ammonium acetate buffer), and
AA was determined by measuring the absorbance of the
reduction product, Cu(I)-neocuproine, at 450 nm against
a reagent blank.  
The absorbances were measured and spectra taken
with an Agilent 8453 UV-Vis spectrophotometer (Agilent
Technologies, Germany) using a pair of matched quartz

cuvettes of 1 cm thickness.  The pH measurements were
made using a Metrohm 632 Digital pH- meter (CH- 9100
Herisau, Switzerland) with a combined glass electrode.
The ionic strength of the reaction medium was maintained at I = 0.1 (KNO3) in order to keep the activity
coefficients of the relevant species constant during the
kinetic process.  All experiments were carried out at 25°C
with a thermostated system (± 0.5°C) which contained an
immersion circulator (Thermomix 1419 B. Braun model,
AG Melsungen, Germany).  
II. Sample Preparation and Kinetic Measurements
All stock solutions were prepared daily. 7.5 × 10 -3
M Nc solution in 96% (v/v) ethanol, 1.0 × 10 -2 M CuCl 2
aqueous solution and 1 M ammonium acetate aqueous solution were used in the determination of AA with
Cu(II)- Nc reagent.
The stock solutions of 1.57 × 10 -4 M of copper(II)
nitrate, 5.67 × 10 -3 M of AA, 1.0 × 10 -2 M acetate buffer
(at pH 4.5) and 1.0 × 10 -2 M of the corresponding amino
acids were prepared in water. In 100 mL flasks of kinetic
measurement, the final concentrations of constituents in
the mixtures were 0.1 M KNO3, 0.0015 M acetate buffer,
1.0 × 10 -4 - 2.0 × 10 -3 M amino acid, 0.785 × 10 -7 - 6.28
× 10 -7 M copper(II) nitrate, and lastly added 5.67 × 10 -4
M ascorbic acid.  Reaction was timed with a chronometer
when AA was added to the sample solution.  The sample
solution flask was placed in a water bath thermostated at
25°C. During this time a stream of air (flow rate = 60
L/h) was passed through the flask and the solution was
saturated with oxygen.   The air was presaturated with
water vapor passed through a wash-bottle.  Since the rate
of reaction was slow compared to the rate of dissolution
of oxygen, the reacting solution was considered saturated with oxygen at all time.   After the addition of ascorbic acid, an aliquot of 0.6 mL was taken every 5 min for
spectrophotometric measurement, and pH of the sample
solution was controlled at the desired level.  The rate of
oxidation was measured for 30 min by quantifying the
residual AA during the course of oxidation.   All tests
were made in triplicate, and the results were presented as
arithmetic means.
Uncatalyzed and cupric amino acid chelate–catalyzed AA (5.67 × 10 -4 M) oxidations were investigated in
mixture solutions containing Cu(II) at 0, 0.785, 1.57, 3.14,
4.71, and 6.28 × 10 -7 M, and amino acid at 0.1, 0.5, 1.0,
and 2.0 × 10 -3 M concentrations.  Note that histidine was
an exception showing the strongest inhibitive effect on
Cu-catalyzed autoxidation of AA, therefore concentrations below 5.0 × 10 -4 M were studied for this amino acid.  
The conditions of temperature, pH, and ionic strength for
these mixtures were as described for all solutions.
III. Procedure for AA Determination
AA was determined by measuring the absorbance
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of the reduction product (i.e., Cu(I)-neocuproine) of the
CUPRAC reagent at 450 nm against a reagent blank(19).
One mL CuCl 2 solution was placed in a test tube, and
then 1 mL of Nc, 1 mL ammonium acetate to bring the
final pH to 7, 1.4 mL of water, and 0.6 mL AA solutions
were added by mixing in this order.  After two minutes,
the absorbance at 450 nm was recorded against a reagent
blank.   All solutions in which copper-catalyzed autoxidation of AA in the absence or presence of amino acid
chelators were followed were analyzed for ascorbic acid
in this manner.   In the linear range of measurement
where Beer’s law was valid, the 450-nm absorbances
were proportional to the concentrations of AA remaining
in solution.

RESULTS

M).  The rate of change of log (absorbance) vs. time (i.e.
slope of linear curves in Figure 1) decreased as the amino
acid concentration was increased, showing catalytic inhibition of AA autoxidation with Cu-binding. The specific
rate constants (K) independent of Cu(II) concentration
were found from the slopes of kd vs [Cu(II)] curves such
as the Cu(II)-aspartic acid-AA system (Figure 2).   The
specific rate constants found with the help of regression
analysis are tabulated in Table 1.   The K values found
for all Cu-chelate systems studied were lower than that
of Cu(II) alone.  Generally for all amino acids, K values
significantly decreased as the amino acid concentrations were increased, showing inhibition of Cu-catalyzed
autoxidation with increased Cu-binding by amino acids.
Among the tested amino acids, the most and least inhibitive Cu-binding ligands were histidine and glutamic acid,

I. Theoretical Considerations

-d [H 2A] / dt = k [H 2A] …  (proportional to A450)
where [H 2A] is the concentration of remaining
ascorbic acid during the course of autoxidation, t is the
time and k is the first-order rate constant which can be
calculated from a plot of log[H 2A] vs. time.   It gives a
straight line with a slope –k / 2.303.   If kd is defined as
the difference between the first-order rate constants in
the presence and absence of copper ions, as defined by
Khan & Martell(3), then the specific rate constant (K)
independent of the metal ion concentration is expressed
with the equation
K = kd / [Cu(II)]
II. Kinetic Findings and Rate Constants
In order to investigate uncatalyzed and cupric amino
acid chelate–catalyzed oxidation of AA in acetate-buffered solution, the Log (absorbance) vs. time data were
analyzed with a linear regression approach.  Such a curve
is given for the Cu(II)-alanine-ascorbic acid system in
Figure 1, using 3.14 × 10 -7 M Cu(II) and varying concentrations of the amino acid (1.0, 5.0, 10.0 and 20.0 × 10 -4
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Figure 1. Kinetic curves for copper-catalyzed autoxidation of AA
Cu(II) at 3.14 × 10 -7 M; alanine at (A: 1, B: 5, C: 10, D: 20) × 10 -4 M
(Log A/ [H 2 A] indicates log value of CUPRAC absorbance due to
ascorbic acid; error bars indicate standard deviations for n = 3 data
points).
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Acidity (pK a) values of ascorbic acid are 4.1 and
11.79(23).   Basically, the undissociated (H 2A) and monoanionic (HA-) forms of ascorbic acid predominated in
solutions in the pH range of 3.2 - 4.5.  Cupric nitrate was
used as the autoxidation catalyst because among the inorganic anions, copper (II) forms the least stable complex
with the relatively weak Lewis base, nitrate.  On the other
hand, sulfate and chloride form more stable complexes
with copper, though all of them are relatively weak.
Oxidation of ascorbic acid in the presence of an
excess of oxygen (saturation) was assumed to follow a first
order reaction(3-5).  The reaction rate can be expressed as
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Figure 2. kd as a function of Cu(II) concentration in aspartic acidcontaining solutions buffered to pH 4.5 with acetate; aspartic acid
concentrations: [(A : 0, B : 1, C : 5, D : 10, E : 20) × 10 -4 M];
kd = difference between first-order rate constants in the presence
and absence of Cu(II); slopes of lines yield K: specif ic rate
constants (error bars indicate standard deviations for n = 6 data
points).
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Table 1. The specific rate constants at pH 4.5 for autoxidation of ascorbic acid catalyzed with amino acid-Cu(II) complexes
AMINO ACID CONCENTRATION  (M)
0.1 × 10
AMINO ACID
Alanine
Aspartic acid
Asparagine

-3

2.0 × 10-3

r2

K±Sk (M-1 min-1)

r2

K±Sk (M-1 min-1)

r2

K±Sk (M-1 min-1)

r2

(7.72 ± 0.21) × 104

0.995

(7.09 ± 0.45) × 104

0.977

(6.76 ± 0.28) × 104

0.990

(5.94 ± 0.36) × 104

0.978

0.997

4

0.986

4

0.996

4

0.953

4

0.961

4

4

(8.13 ± 0.22) × 10

4

(7.92 ± 0.39) × 10

Phenylalanine

(7.05 ± 1.20) × 10

Glycine
Glutamic acid

Histidine

1.0 × 10-3

K±Sk (M-1 min-1)

4

Glutamine

0.5 × 10-3

0.990

(7.02 ± 0.41) × 10

4

(6.77 ± 0.53) × 10

0.896

4

(5.00 ± 0.24) × 10

(8.12 ± 0.98) × 104

0.944

(9.94 ± 0.52) × 104
4

(8.68 ± 0.72) × 10

4

(7.98 ± 0.48) × 10

0.976

(4.49 ± 0.14) × 10

4

(4.67 ± 0.49) × 10

0.957

(3.64 ± 0.40) × 10
(3.24 ± 0.33) × 10

0.991

4

(3.67 ± 0.25) × 10

0.981

(3.35 ± 0.32) × 10

0.965

(7.79 ± 0.90) × 104

0.948

(6.30 ± 0.57) × 104

0.969

(5.82 ± 0.12) × 104

0.998

0.989

(9.27 ± 0.46) × 104

0.990

(8.32 ± 0.66) × 104

0.975

(6.54 ± 0.48) × 104

0.979

0.973

4

0.972

4

0.997

4

0.975

4

0.952

0.986

(8.00 ± 0.68) × 10
(3.67 ± 0.41) × 10
-1

(7.90 ± 0.23) × 10

(5.64 ± 0.45) × 10

For Cu(II) alone       (without amino acid)        K±Sk (M min ) = (11.89± 0.20) × 104 (r2 = 0.999)
Sk = The standard deviation of K values, r2 = regression coefficient (squared)
K = Specific rate constant independent of concentration, K 

-1

kd
[Cu ( II )]

respectively.
In general, the kinetic properties of Cu-catalyzed
autoxidation of AA in the presence of amino acids (Table
1) can be summarized as follows:
- The reaction rates increased with increasing Cu(II)
concentration.
- For different combinations of Cu(II) and amino
acids, the oxidation rate decreased with increasing amino
acid concentration, especially at high amino acid levels,
e.g. 1.0 × 10 -3 - 2.0 × 10 -3 M.
- In Cu-catalyzed autoxidation of AA, the specific
rate constants (K) decreased with increasing amino acid
concentrations.
- The effects of the pairs; glutamic acid and glutamin, aspartic acid and asparagine, or glycine and alanine,
were not significantly different.
- The inhibitive effect of phenylalanine was greater
than that of alanine.
- Since the inhibitive effect of histidine was predominant at increasing levels of the amino acid, kinetic
experiments could not be designed at relatively high
concentrations (i.e., 1.0 × 10 -3 - 2.0 × 10 -3 M).
- The rate of change of inhibition observed with
increasing amino acid concentration was greater for
aspartic acid than for glutamic acid (as reflected in the
variation of the corresponding K values tabulated in
Table 1).

first-order kinetics. The autoxidation rate constant
increased with Cu(II) concentration, and decreased with
amino acid concentration for a given Cu(II) level(24).
Since acetate was used as the buffer medium (at
pH 4.5), the possibility of acetate complexation of Cu(II)
should be considered in kinetic evaluation.   The cumulative stability constants (Logβn) of the Cu(II)–acetate
complexes are 2.16 and 3.2 for mono- and bis- complexes, respectively (25).   Authors of this work have recently
established that aspartame, a dipeptide synthesized from
phenylalanine and aspartic acid, significantly inhibited Cu-catalyzed oxidation of AA in acetate-buffered
media (26).   Free aquated Cu 2+ ion and the weak Cu(II)acetate complex were shown to catalyze AA oxidation to
a greater extent than the relatively stable Cu(II)-aspartame complex.   The stability constants (Logβn) of the
Cu(II)–aspartame complexes were 6.097 and 10.84 for
CuL+ and CuL2 , respectively(27), rendering cupric ion
complexation with aspartame predominant in acetatebuffered solutions.
Khan and Martell(4) postulated the following mechanism for ascorbic acid (H 2A) autoxidation catalyzed by
a transition metal (M) chelated with a ligand (L) in the
form of a relatively stable complex (MLn+) :

→ HA- + H+
H 2A ←
HA- + MLn+ ←
→ MHLA(n-1)
+

DISCUSSION

MHLA(n-1)

Kinetic evaluation of experimental data showed
that Cu-catalyzed autoxidation of ascorbic acid (AA) in
acetate-buffered solution at pH 4.5 conformed to pseudo

MHLA•(n-1)

+

+

→ MHLA•(n-1)+
rapid→

A•- + ML (n-1)

A•- +  MLn+   rapid→ A + ML (n-1)

+

+
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In this catalytic process, the catalyst MLn+ chelate
can be regenerated by oxidation of ML (n-1)+ with
dissolved oxygen (thus, ascorbic acid, denoted as H 2A, is
2-e oxidized to dehydroascorbic acid, A).   In the multistep process, the slow, rate-limiting step is the formation of the ternary transition complex, MHLA(n-1)+
from monohydrogen ascorbate (HA-) and Cu(II)-chelate
(MLn+).  If the binary M-L chelate is extremely stable, the
ternary transition complex may not form quantitatively.  
Weak bonding in the transition complex may lead to easy
deformation of this complex during electron transfer.  
In this respect, Khan and Martell(4) postulated that the
autoxidation rate of AA in the presence of cupric chelates
would decrease with increasing stability of the metal
complexes, and found linear relationship in the catalytic
activity of chelates as a function of logarithmic stability
constant of the corresponding complex.   In accordance
with this postulate, the extremely stable cupric chelates
with phenanthroline, dipyridyl(4), and thiourea (28) were
shown to be completely inactive in catalyzing AA autoxidation.   The postulated mechanism requires that the
copper chelate with the amino acid ligand form a ternary transition complex with the ascorbic acid monoanion
(HA-) which may be converted to the Cu(I)-chelating
amino acid complex and the radical product of ascorbic acid (HA.) in a slow reaction(8).   The ascorbyl radical responsible for the ultimate reaction with molecular
oxygen (ascorbic acid itself being converted to dehydroascorbic acid)(7) was detected in the Cu(II)-histidine-AA
reaction system by ESR techniques (9).  In this work, AA
autoxidation was expected to be more inhibited in the
presence of more stable Cu(II)-L chelates with amino
acids due to weaker bonding of the transition complex
with hydrogen ascorbate (HA-).  
The specific rate constants (K) for AA autoxidation listed in Table 1 reveal that the inhibitive potency of
Cu(II)-ligand chelates for the tested amino acids followed
the order: histidine > phenylalanine ≥ asparagine ≥ aspartic acid ≥ alanine ≥ glycine > glutamine > glutamic acid.
Stability constants (Log β1) at different ionic

strengths of the studied amino acids with Cu(II) were
as follows: histidine (10.2-10.6) , phenylalanine (7.88.0), asparagine (7.9), aspartic acid (8.4), alanine (8.3),
glycine (8.2), glutamine (7.75), glutamic acid (7.85)(29).  
In order to precisely correlate the stabilities of the
amino acid complexes to their inhibition potencies, it is
better to calculate the conditional stability constants of
these complexes at the working pH of 4.5.   Moreover,
since amino acids act as bidentate ligands for copper at
pH values where they are sufficiently ionized, 1:2 metal
(M)-ligand (L) complexes (ML2) may form simultaneously with 1:1 (ML) complexes, and therefore, it would
be more precise to consider the second cumulative stability constans (Log β2) in the correlations.   A theoretical
analysis comprising these considerations is given below:
M + 2 L ↔ ML2 … β2 = [ML2] / ([M] [L]2)
[L] = CH2L α L (where CH2L: total amino acid concn. ;
α L: relative abundance of L)
For diprotic amino acids (H 2L), α L = Ka1Ka2 / ([H+]2 +
Ka1 [H+] + Ka1Ka2), and for triprotic amino acids (H3L),
α L = Ka1Ka2Ka3 / ([H+]3 + Ka1 [H+]2 + Ka1Ka2 [H+] +
Ka1Ka2Ka3). Thus,
β2 = [ML2] / ([M] C2H2L α 2L) and β’2 = β2 α 2L
where β’2 is the conditional second cumulative stability
constant of the ML2 complex.   For an informative evaluation, this constant has to be correlated to inhibition of
copper-catalyzed autoxidation (Table 2).   The percentage
inhibition, I (%), can be defined as:
I (%) = 100 (KCu(alone) - Kcomplex) / KCu(alone)
For example, for 1.0 × 10 -3 M alanine, I (%) = 43.1 by
taking KCu(alone) =11.89 × 104 (Table 1).
The specific inhibition (Is) is then defined as the mean
percentage inhibition per unit concentration of amino acid,
i.e. Is = I (%) / CH2L.   Statistical analysis (t-test at 95%

Table 2. Specific inhibition (Is) of copper-catalyzed autotoxidation of ascorbic acid by various amino acids (Is is correlated to conditional
second cumulative stability constant, β’2)
Amino acid

pKa1

pKa2

pKa3

Log β1

Log β2

β’2

αL
-7

Log β’2

Is

5

5.98

2.34 × 105

histidine

1.8

6.1

9.2

10.6

18.6

4.88 × 10

9.48 × 10

phenylalanine

2.2

9.1

-

7.9

14.7

2.50 × 10-5

3.13 × 105

5.50

1.57 × 105

asparagine

2.1

8.8

-

7.9

14.45

5.0 × 10-5

7.02 × 105

5.85

1.29 × 105

aspartic acid

2.1

3.7

9.6

8.4

15.2

6.85 × 10-6

7.44 × 104

4.87

1.24 × 105

alanine

2.4

9.7

-

8.3

15.1

6.26 × 10-6

4.93 × 104

4.69

1.25 × 105

glycine

2.3

9.7

-

8.2

14.9

6.27 × 10-6

3.12 × 104

4.49

1.15 × 105

glutamine

2.2

9.0

-

7.75

14.25

3.15 × 10-5

1.76 × 105

5.24

9.88 × 104

glutamic acid.

2.3

4.3

9.7

7.85

14.4

3.86 × 10-6

3.74 × 103

3.57

6.51 × 104
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confidence level)(30) confirmed that a significant correlation did exist between β’2 and Is.  The valid correlation
equations for the data in Table 2 are:

gistic combinations of antioxidants, e.g. a chain-breaking
antioxidant (ascorbic acid) and a metal-sequestering antioxidant (amino acid).

β’2    =   5.71 Is   – 4.61 × 105 ;   r = 0.7990  and
Log β’2 = 4.14 Log Is – 16.05 ;   r = 0.8275.
It is clear from these data that as the conditional stability
of the copper-amino acid complex increased at the working pH of 4.5, the specific inhibition of the copper-catalyzed ascorbic acid autoxidation increased, in accordance
with the hypothesis of Khan and Martell(4).   Since the
studied amino acids are the building blocks of proteins,
they can have a protective role for the prevention of transition metal–catalyzed ascorbic acid oxidation that may
give rise to the generation of free radicals via reactions:
2 Cu(II) + ascorbic acid → 2 Cu(I) + dehydroascorbic acid
Cu+ + H 2O2 → Cu 2+ + • OH + OHand thereby cause tissue damage.  It has been well established in literature that such uncontrolled Fenton reactions produce the most powerful oxidant species, the
hydroxyl radical, that attack biological macromolecules
such as lipid, protein, and DNA, causing oxidative degradation in these macromolecules and damage in cellular tissues (31,32).   Under certain conditions of transition
metal catalysis, ascorbic acid may act as a pro-oxidant
instead of its usual function as antioxidant, and the presence of such amino acids as copper sequesterants may be
the most efficient means of preventing such degradation
reactions.  It should be indicated that the concentration of
amino acid was optimally taken in excess of either ascorbic acid or Cu(II) in this study to observe the mentioned
protective effect.   Otherwise, an excess of uncomplexed
Cu(II) might easily induce the prooxidant effect of AA,
which led some researchers in the past to conclude that
the copper-ligating substance increased the rate of Cucatalyzed autoxidation of AA(33).
The basic amino acid residues existing on proteins
that are responsible for copper binding with concomitant
formation of bioinorganic complexes exhibiting various
oxidant and antioxidant activities have been identified as
histidine, cysteine, and tryptophan moieties (34).  There is
important evidence showing that those proteins and polypeptides exhibiting pro-oxidant behaviour (i.e. inducing
oxidative stress, either through creating reactive oxygen
species or inhibiting antioxidant systems) by copper binding may lead to neurodegenerative diseases (35,36).   The
specific rate constants show that histidine is the strongest inhibitor of Cu-catalyzed AA autoxidation among
the tested amino acids (Table 1).  This may be related to
the specific health-beneficial role of histidine in being
primarily responsible for copper binding and transport in
human and mammal serum(37). The findings of this study
may also be useful in understanding the possible syner-

CONCLUSIONS
Free Cu 2+ ion was shown to catalyze AA oxidation
to a greater extent than the relatively stable Cu(II)-amino
acid complexes. This finding supports the conclusion of
Khan and Martell that as the stability of a Cu(II) complex
increases, its catalytic activity as a mediator of electrontransfer in AA oxidation decreases(3,4).  Since amino acids
are physiologically compatible ligating agents in the food
and biochemical era, they may help to protect AA values
by retarding transition metal-catalyzed oxidation.  Amino
acids could also be useful in stabilizing mixture solutions
of AA with a transition metal ion, which would otherwise yield Fenton-like reactions(14) causing hydroxyl radical-induced degradations, thereby aiding the conservation of foods and beverages.   This is important, as it has
been established that antioxidants in food such as ascorbic
acid may act as pro-oxidants by reducing transition metal
ions like Cu(II) to the lower oxidation state and make the
strongly oxidizing hydroxyl radical generation catalytic(38).   The AA-protective effect of amino acids in pharmaceutical products by retarding metal-catalyzed oxidation of AA can be exploited in formulations containing
vitamin C with relatively high water activity.  The experimental work adopted for following ascorbic acid degradation is also important, as the remaining AA in solution
is spectrophotometrically monitored with a copper(II)neocuproine (CUPRAC) assay(20,21) that is not influenced
by amino acids and many other organic compounds that
normally interfere with conventional UV-spectrometric
assays.  Among the studied amino acids, histidine showed
the strongest inhibitive effect on copper-catalyzed AA
autoxidation. This may be related to the specific function
of histidine as copper transport amino acid in the serum
of humans and mammals(37). The findings of this study
may also be useful in understanding the possible synergistic combinations of antioxidants, such as ascorbic acid and
amino acid combinations.

ABBREVIATIONS
AA:
EDTA:
CDTA:
NTA:
ESR:
HA- :
HA. :
H 2A:
Nc :

Ascorbic acid  
Ethylenediamine tetraacetic acid
Cyclohexanediamine tetraacetic acid
Nitrilotriacetic acid
Electron spin resonance  
Monoanionic form of ascorbic acid
Ascorbic acid radical
Undissociated form of ascorbic acid
Neocuproine: 2,9-dimethyl-1,10-phenanthroline
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CUPRAC: Cupric ion reducing antioxidant capacity
TAC :
Total Antioxidant Capacity
UV-Vis : Ultraviolet-Visible
Ka :
Acidity constant
βn :
Cumulative complex formation constant
k:
First-order rate constant of copper-catalyzed
AA autoxidation
kd :	Difference between first-order rate constants in
the absence and presence of amino acids
K :	Specific rate constant independent of copper
concentration
SK :
Standard deviation of K values
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